Regarding the efficient folding catalyzed by ERp46, knockdown of ERp46 in cultured β-cells leads to a significant decrease in insulin production.90 Therefore, ERp46 plays a role in β-cell dysfunction and is a therapeutic target in the treatment of diabetes. Here, TXNDC5 is linked to diabetes mellitus.